Alix E. Seif, MD, MPH

faculty photo
Associate Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
Core Faculty, CHOP Clinical Futures
Innovation Faculty, Penn Center for Cancer Care Innovation (PC3I)
Director of Clinical Research, Center for Childhood Cancer Research, Division of Oncology, The Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Oncology
3500 Civic Center Blvd, HUB 3529
Philadelphia, PA 19104
Office: 215-590-9996
BA (Linguistics - Honours, First Class)
McGill University, 1992.
MA (Linguistics)
McGill University, 1995.
MPH (Epidemiology and Biostatistics)
Oregon Health Sciences University, 2002.
Oregon Health Sciences University, 2002.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Kerby EH, Li Y, Getz KD, Smith EC, Smith LT, Bunin NJ, Seif AE: Nutritional risk factors predict severe acute graft-versus-host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 65: e26853, Feb 2018.

Rolf N, Smolen KK, Kariminia A, Velenosi A, Fidanza M, Strahlendorf C, Seif AE, Reid GSD: Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia. Cancer Immunol Immunother 67(2): 225-236, Feb 2018.

Citrin R, Horowitz JP, Reilly AF, Li Y, Huang YS, Getz KD, Seif AE, Fisher BT, Aplenc R: Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database. PLOS One 12(10): e0186960, Oct 2017.

Winestone L, Getz KD, Miller TP, Li Y, Huang Y-S, Seif AE, Fisher BT, Aplenc R: Complications preceding early deaths in black and white children with acute myeloid leukemia. Pediatr Blood Cancer 64: e26712, Dec 2017.

Elgarten CW, Arnold DE, Bunin NJ, Seif AE: Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin-inhibitors as prophylaxis for graft-versus-host disease. Pediatr Blood Cancer 65(1): e26726, Jan 2018.

Miller TP, Li Y, Kavcic M, Getz KD, Huang YV, Sung L, Alonzo TA, Gerbing R, Daves MH, Horton TM, Pulsipher MA, Pollard J, Bagatell R, Seif AE, Fisher BT, Luger S, Gamis AS, Adamson PC, Aplenc R: Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group. Haematologica 102(9): e340-e343, Sep 2017.

Fidanza M, Seif AE, Jo S, Kariminia A, Rolf N, Sly LM, Grupp SA, Reid GS: IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life. Eur J Immunol 47: 892-9, May 2017.

Winestone LE, Getz KD, Miller TP, Wilkes JJ, Sack L, Li Y, Huang Y-S, Seif AE, Bagatell R, Fisher BT, Epstein AJ, Aplenc R: The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia. Am J Hematol 92(2): 141-148, Feb 2017.

Miller TP, Li Y, Getz KD, Dudley J, Burrows E, Pennington J, Ibrahimova A, Fisher B, Bagatell R, Seif AE, Grundmeier RW, Aplenc R: Using electronic medical record data to report laboratory adverse events. Br J Haematol 177(2): 283-6, Feb 2017.

Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GSD, Seif AE: Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia. Leukemia 32(2): 539-42, Feb 2018.

back to top
Last updated: 06/13/2024
The Trustees of the University of Pennsylvania